Extracellular proteasome-osteopontin circuit regulates cell migration with 
implications in multiple sclerosis.

Dianzani, C.; Bellavista, E.; Liepe, J.; Verderio, C.; Martucci, M.; Santoro, A.; Chiocchetti, A.; Gigliotti, C. L.; Boggio, E.; Ferrara, B.; Riganti, L.; Keller, C.; Janek, K.; Niewienda, A.; Fenoglio, C.; Sorosina, M.; Cantello, R.; Kloetzel, P. M.; Stumpf, M. P. H.; Paul, F.; Ruprecht, K.; Galimberti, D.; Boneschi, F. M.; Comi, C.; Dianzani, U.; Mishto, M.

doi:10.1038/srep43718

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Zeitschriftenartikel

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.

MPG-Autoren

/persons/resource/persons208298

Liepe, J.
Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society;

Externe Ressourcen

Es sind keine externen Ressourcen hinterlegt

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

2486215.pdf
(Verlagsversion), 2MB

Ergänzendes Material (frei zugänglich)

2486215_Suppl.pdf
(Ergänzendes Material), 4MB

Zitation

Dianzani, C., Bellavista, E., Liepe, J., Verderio, C., Martucci, M., Santoro, A., et al. (2017). Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis. Scientific Reports, 7: 43718. doi:10.1038/srep43718.

Zitierlink: https://hdl.handle.net/11858/00-001M-0000-002D-FDFA-5

Zusammenfassung

Osteopontin is a pleiotropic cytokine that is involved in several diseases including multiple sclerosis. Secreted osteopontin is cleaved by few known proteases, modulating its pro-inflammatory activities. Here we show by in vitro experiments that secreted osteopontin can be processed by extracellular proteasomes, thereby producing fragments with novel chemotactic activity. Furthermore, osteopontin reduces the release of proteasomes in the extracellular space. The latter phenomenon seems to occur in vivo in multiple sclerosis, where it reflects the remission/relapse alternation. The extracellular proteasome-mediated inflammatory pathway may represent a general mechanism to control inflammation in inflammatory diseases.